Treace Medical Concepts, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Treace Medical Concepts, Inc. (TMCI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 877.91 thousand shares for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2023-11-09
- Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 106.13K shares, a 59.59% increase year-over-year.
- Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-06-30 was 44.13K shares, a 78.72% decline year-over-year.
- Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-03-31 was 727.65K shares, a 24.50% decline year-over-year.
- Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-09-30 was 66.50K shares, a 83.98% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2023-09-30 | 106.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 150.26K shares derived: sum of 2 quarters · filed 2023-11-09 | 877.91K shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 44.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 771.78K shares 10-Q · filed 2023-08-09 | |
| 2023-03-31 | 727.65K shares 10-Q · filed 2023-05-09 | ||
| 2022-09-30 | 66.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 273.88K shares derived: sum of 2 quarters · filed 2023-11-09 | 1.24M shares 10-Q · filed 2023-11-09 |
| 2022-06-30 | 207.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 1.17M shares 10-Q · filed 2023-08-09 | |
| 2022-03-31 | 963.80K shares 10-Q · filed 2023-05-09 | ||
| 2021-09-30 | 415.13K shares 10-Q · filed 2021-11-04 | 1.28M shares derived: sum of 2 quarters · filed 2021-11-04 | 1.79M shares 10-Q · filed 2022-11-09 |
| 2021-06-30 | 863.72K shares 10-Q · filed 2021-08-05 | 1.38M shares 10-Q · filed 2022-08-10 | |
| 2021-03-31 | 511.59K shares 10-Q · filed 2022-05-06 | ||
| 2020-09-30 | 280.00K shares 10-Q · filed 2021-11-04 | 297.50K shares derived: sum of 2 quarters · filed 2021-11-04 | 659.73K shares 10-Q · filed 2021-11-04 |
| 2020-06-30 | 17.50K shares 10-Q · filed 2021-08-05 | 379.73K shares 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |